Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial.
Zeymer U, Schröder R, Tebbe U, Molhoek GP, Wegscheider K, Neuhaus KL. Zeymer U, et al. Among authors: tebbe u. Eur Heart J. 2001 May;22(9):769-75. doi: 10.1053/euhj.2000.2290. Eur Heart J. 2001. PMID: 11350109 Clinical Trial.
Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).
Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M, Bonzel T, Senges J, Neuhaus KL; Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Zeymer U, et al. Among authors: tebbe u. Eur Heart J. 2004 Feb;25(4):322-8. doi: 10.1016/j.ehj.2003.12.008. Eur Heart J. 2004. PMID: 14984921
Frequency of "optimal anticoagulation" for acute myocardial infarction after thrombolysis with front-loaded recombinant tissue-type plasminogen activator and conjunctive therapy with recombinant hirudin (HBW 023). ALKK Study Group.
Zeymer U, von Essen R, Tebbe U, Niederer W, Mäurer W, Vogt A, Neuhaus KL. Zeymer U, et al. Among authors: tebbe u. Am J Cardiol. 1995 Nov 15;76(14):997-1001. doi: 10.1016/s0002-9149(99)80283-5. Am J Cardiol. 1995. PMID: 7484879
316 results